naltrexone and Mood Disorders

naltrexone has been researched along with Mood Disorders in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19904 (28.57)18.7374
1990's1 (7.14)18.2507
2000's4 (28.57)29.6817
2010's5 (35.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acevedo, LM; Apovian, CM; Dunayevich, E; Greenway, FL; McElroy, SL; Pi-Sunyer, X1
Howland, RH1
Spada, MM1
Cree, BA; Goodin, DS; Kornyeyeva, E1
Dundon, WD; O'Brien, CP; Pettinati, HM1
Grinenko, AIa; Krupitskiĭ, EM; Zvartau, EE1
Koppeschaar, HP; Schagen Van Leeuwen, JH; Te Velde, ER; Van Ree, JM1
Collins, J; Cramer, J; Gueorguieva, R; Krystal, JH; Rosenheck, R1
Martin, WR1
Anderson, B; Koz, G; Volavka, J1
Kagaya, A; Kugaya, A; Uchitomi, Y; Yamawaki, S; Yokota, N1
Agman, G; Godart, NT; Jeammet, P; Perdereau, F1
Peachey, JE1
Dickerson, PC; Malcolm, R; O'Neil, PM; Von, JM1

Reviews

2 review(s) available for naltrexone and Mood Disorders

ArticleYear
An overview of problematic internet use.
    Addictive behaviors, 2014, Volume: 39, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Internet; Methylphenidate; Mood Disorders; Naltrexone; Narcotic Antagonists; Prevalence; Substance-Related Disorders

2014
Current status of co-occurring mood and substance use disorders: a new therapeutic target.
    The American journal of psychiatry, 2013, Volume: 170, Issue:1

    Topics: Alcoholism; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Controlled Clinical Trials as Topic; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Drug Therapy, Combination; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Psychotropic Drugs; Sertraline; Substance-Related Disorders

2013

Trials

6 trial(s) available for naltrexone and Mood Disorders

ArticleYear
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
    Annals of neurology, 2010, Volume: 68, Issue:2

    Topics: Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Pilot Projects; Placebos; Quality of Life; Young Adult

2010
[Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:10

    Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Double-Blind Method; Drug Therapy, Combination; Heroin Dependence; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome

2003
Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids.
    Psychopharmacology, 2005, Volume: 182, Issue:2

    Topics: beta-Endorphin; Double-Blind Method; Female; Humans; Mood Disorders; Naltrexone; Opioid Peptides; Pilot Projects; Placebo Effect; Premenstrual Syndrome; Surveys and Questionnaires

2005
Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Alcoholism, clinical and experimental research, 2008, Volume: 32, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Antidepressive Agents; Female; Humans; Male; Mood Disorders; Naltrexone; Narcotic Antagonists; Stress Disorders, Post-Traumatic; Treatment Outcome

2008
Naloxone and naltrexone in mental illness and tardive dyskinesia.
    Annals of the New York Academy of Sciences, 1982, Volume: 398

    Topics: Animals; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Endorphins; Humans; Mood Disorders; Naloxone; Naltrexone; Rats; Schizophrenia

1982
Naltrexone and dysphoria: a double-blind placebo controlled trial.
    Biological psychiatry, 1987, Volume: 22, Issue:6

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Naltrexone; Sex Factors

1987

Other Studies

6 other study(ies) available for naltrexone and Mood Disorders

ArticleYear
Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis.
    International journal of obesity (2005), 2019, Volume: 43, Issue:10

    Topics: Anti-Obesity Agents; Bupropion; Double-Blind Method; Drug Combinations; Humans; Mood Disorders; Naltrexone; Obesity; Overweight; Prospective Studies; Randomized Controlled Trials as Topic

2019
Therapies for obesity and medication-associated weight gain.
    Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:5

    Topics: Animals; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Chronic Disease; Combined Modality Therapy; Diet, Reducing; Disease Models, Animal; Drug Combinations; Exercise; Fructose; Humans; Mood Disorders; Naltrexone; Obesity; Overweight; Phentermine; Psychotic Disorders; Randomized Controlled Trials as Topic

2013
Emerging concepts concerning drug abuse.
    NIDA research monograph, 1980, Volume: 30

    Topics: Adolescent; Adult; Animals; Cats; Conditioning, Psychological; Cyclazocine; Dogs; Euphoria; Guinea Pigs; Homeostasis; Humans; Models, Biological; Mood Disorders; Morphine Dependence; Naltrexone; Rats; Receptors, Opioid; Substance-Related Disorders

1980
Effect of interferon-alpha on DOI-induced wet-dog shakes in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:8-9

    Topics: Amphetamines; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Injections, Intraventricular; Interferon alpha-2; Interferon-alpha; Male; Mood Disorders; Motor Activity; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists

1996
Naltrexone treatment of self-injurious behavior.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2000, Volume: 39, Issue:9

    Topics: Adolescent; Drug Therapy, Combination; Eye Injuries; Humans; Male; Mood Disorders; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Psychotic Disorders; Psychotropic Drugs; Self-Injurious Behavior; Treatment Outcome

2000
The role of drugs in the treatment of opioid addicts.
    The Medical journal of Australia, 1986, Oct-20, Volume: 145, Issue:8

    Topics: Alcoholism; Anxiety; Clonidine; Dextropropoxyphene; Heroin; Humans; Inactivation, Metabolic; Kinetics; Methadone; Mood Disorders; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

1986